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Background: Insufficient vitamin D activity has attracted increasing interest as a possible underlying risk factor in
disorders of the central nervous system, including autism.
Methods: In this study, 25-hydroxyvitamin D (25(OH)D) was analysed in 58 Sweden-born sibling pairs, in which one
child had autism spectrum disorder (ASD) and the other did not. The study group consisted of two representative
samples; 47 Gothenburg sibling pairs with mixed ethnicities and 11 Stockholm sibling pairs with Somali background.
25(OH)D levels were analysed in the stored dried blood spots taken in the neonatal period for metabolic screening.
Results: The collapsed group of children with ASD had significantly lower vitamin D levels (M = 24.0 nM, SD = 19.6) as
compared with their siblings (M = 31.9 nM, SD = 27.7), according to a paired samples t-test (P = 0.013). The difference
was - most likely - not only accounted for by a difference in season of birth between ASD and non-ASD siblings
since the mean 25(OH)D levels differed with similar effect size between the sibling pairs born during winter and
summer, respectively. All children with African/Middle East background, both the children with ASD and their
non-ASD siblings, had vitamin D deficiency.
Conclusions: The findings suggest that low prenatal vitamin D may act as a risk factor for ASD, however, there is a
need for replication with larger samples. Future research should study whether or not adequate supplementation
of vitamin D to pregnant women might lower the risk for ASD in the offspring.
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Autism spectrum disorders (ASDs) belong to a group of
neurodevelopmental conditions that are usually of prenatal
origin and, when severe, detected in early childhood. The
symptoms comprise a broad range of social-communicative
impairments, accompanied by repetitive behaviours and
sensory abnormalities. ASD frequently coexists with other
cognitive/behavioural/neurological disorders, including in-
tellectual disability, language disorder, attention-deficit/
hyperactivity disorder (ADHD) and epilepsy, that is, disor-
ders comprised under the ESSENCE concept (Early Symp-
tomatic Syndromes Eliciting Neurodevelopmental Clinical
Examinations) [1].* Correspondence: elisabeth.fernell@gnc.gu.se
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unless otherwise stated.As regards current studies examining ASD aetiology,
genetic factors dominate. However, the importance of
interacting environmental factors are increasingly being
recognised [2,3]. Autoimmunity [4,5], pre- (and some post-)
natal infections [6-8], exposure to thalidomide, valproic
acid or alcohol during pregnancy [9-11], and older paren-
tal age [12] have all been associated with autism. Among
perinatally acquired conditions, extreme preterm birth en-
tails an increased risk for neurodevelopmental disorders,
including autism [13]. However in spite of extensive re-
search, the relative impact of various pathogenic mecha-
nisms is still insufficiently understood.
Low vitamin D availability has attracted increasing inter-
est as an aetiological factor in disorders of the central ner-
vous system. The initial discovery that rodent brains
contain vitamin D receptors, targeted by calcitriol, the
hormonally active form of vitamin D, was crucial for this
research [14]. The distribution of the vitamin D receptorThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and Privette [16] first suggested that vitamin D deficiency
in adults might contribute to the pathogenesis of certain
psychiatric disorders, including depression. Later, the
negative impact of prenatal vitamin D deficiency on
brain development was postulated by McGrath [17],
mainly based on epidemiological data. Further research
has shown that vitamin D has a role in brain development
and function, including neuronal differentiation, axonal
connectivity, dopamine ontogeny, immunological modula-
tion and transcriptional control over a large number of
genes [18-21]. Prenatal vitamin D deficiency has now
been proposed as a risk factor for neurodevelopmental
disorders such as schizophrenia [22] and autism [23-27].
Several epidemiological findings indirectly support a
possible role for prenatal vitamin D deficiency in autism.
For example, dark-skinned immigrants in countries with
relative lack of sun have an elevated autism prevalence
[28-31]. This is relevant since the synthesis of vitamin D
in skin is impaired by melanin [32]. However, the in-
creased risk for autism determined by ethnicity is unre-
lated to the ethnicity of the father, further implicating
the role of fetal environment [33,34]. Children born to
immigrants of Somali origin in Sweden [28,29] as well as
in Minnesota [35], have a very high prevalence of severe
ASD with intellectual disability and extreme hyperactivity.
Many studies in Europe have documented that dark-
skinned immigrants and those wearing concealing clothes
have consistently lower 25-hydroxyvitamin D (25(OH)D)
levels compared to pale-skinned indigenous populations
[36-39], with African girls at highest risk [40].
Season of birth findings constitute another link between
autism and vitamin D. In Europe a major proportion of
the population have considerably lower 25(OH)D in win-
ter and spring compared to summer and autumn [36,41].
A number of studies in Sweden, Denmark, UK and
north-east USA on season of birth have shown that
more children with ASD are born in winter and spring
[42,43], with highest relative rates in March [44,45] sug-
gesting that lower vitamin D status in the mother during
pregnancy may constitute a risk factor [46]. The absence
of season of birth effect in Israel [47] and California [48]
could be explained by high insolation throughout the year.
A number of studies from different parts of the world,
such as Sweden, Egypt and China, report lower 25(OH)
D levels in individuals of different ages with ASD com-
pared to controls [49-53]. In none of these studies can
reversed causation be excluded, that is, low 25(OHD)
levels resulting from ASD symptoms, such as restricted
diet and/or more prevalent indoor dwelling. However, to
our knowledge there has been no study analysing vitamin
D levels in samples taken in the neonatal period.
The aim of the present study was to address the emer-
ging hypothesis that low levels of vitamin D at birthincrease the risk for ASD. We examined 25(OH)D levels
in dried blood spot samples taken during the neonatal
period from children born in Sweden, who later were di-
agnosed with ASD. We used their siblings without ASD
as a joint environmental and genetic control group.
Additional contributing factors such as ethnicity, birth
order and season of birth were also examined.
Subjects and methods
Subjects
A total of 58 sibling pairs were included in the study. In-
clusion criteria for the children with ASD were: (1) having
been diagnosed with ASD without a known cause accord-
ing to clinical/neurological assessments, such as Rett syn-
drome, Fragile X and Tuberous sclerosis during preschool
age; (2) having a non-ASD sibling aged 4 years or older;
and (3) parents giving consent to assessment of vitamin D
status and CMV-infection status (for a separate study) of
the ASD and non-ASD affected siblings at birth from
dried blood spots. The children were recruited from two
different sources, constituting distinct cohorts.
The first cohort, the Gothenburg catchment area group,
consisted of 240 children with ASD born in Sweden be-
tween 2005 and 2008 living in the Gothenburg catchment
area (approximately 6,000 births/year). The majority of
the children in this group had been identified in connec-
tion with general population screening at 30 months of
age and others had been referred for assessment on clin-
ical grounds. These children had been comprehensively
assessed by a multi-professional expert team, specialising
in ASD and other neurodevelopmental disorders at the
Child Neuropsychiatry Clinic in Gothenburg [54]. Parents
of these children were asked to give consent to have their
child and his/her non-ASD sibling included in the present
study. Consent was provided by 52% of the parents. How-
ever, in five cases, the siblings first presumed to be a non-
ASD sibling, turned out to also have ASD, increasing the
total ASD group to 245 children. A total of 74 children
were excluded due to not having a non-ASD sibling, only
having a half-sibling or only having a sibling aged younger
than 4 years. Another two children had to be excluded be-
cause they were adopted, and thus not biologically related
to their mother. Three children were excluded since their
dried blood spot tests could not be retrieved. One child
with a specific brain tumour (ganglioglioma) was also ex-
cluded. Of the remaining 47 sibling pairs, 28 had child-
hood autism, 16 atypical autism and three had Asperger’s
syndrome (Figure 1). Two of the children with ASD were
siblings and a third sibling served as a control for both.
The boy:girl ratio was 8.4:1 (42 boys, 5 girls). With regard
to coexisting disorders, 11 also had intellectual disability,
13 had borderline intellectual functioning/developmental
delay but not definitely intellectual disability, and 23 had
average intellectual function. One child had epilepsy.
Figure 1 Participants flow. ASD, autism spectrum disorder; DBS, dried blood spots.
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tially comprised 40 preschool and school children, born in
Sweden between 1990 and 2005 by Somali-born parents.
This cohort had been assessed at child neuropsychiatric
and/or neuropaediatric clinics in Stockholm County by
multi-professional expert teams. They were diagnosed
with childhood autism combined with intellectual disabil-
ity and had previously been included in prevalence studies
of autism in children with Somali background and their
mothers in a vitamin D study [26,28,29]. Letters of request
to participate in the study were sent to the parents. A total
of 15 parents gave consent to the study. However one
child could not be identified at the ‘PKU laboratory’, that
is, the Centre for Inherited Metabolic Diseases, see below,
and another three did not have a sibling aged 4 years
or older. Thus, analyses were performed in a total of
11 Somali sibling pairs consisting of one child with
ASD and a non-ASD sibling. The boy:girl ratio was 9:1
(9 boys, 1 girl) (Figure 1).
Ethnicity
The Gothenburg children were of mixed ethnicities; 28
of the mothers were of Swedish origin, five had other non-
Scandinavian European origin, four had South American
origin, seven had origins in the Middle East and three had
origins in East Asia. Ethnic origin was self-reported during
interview. All 11 pairs from Stockholm had parents born
in Somalia.
Due to the well-known ethnic disparity of vitamin D
status, we chose to categorise the participants into threeethnic origin groups: Swedish, Miscellaneous (non-
Scandinavian Europe, South America and East Asia)
and African/Middle East.Methods
Stored dried blood spots
In Sweden, all newborns are tested for certain neuro-
metabolic disorders. Peripheral blood (50 μL) is collected
onto a filter paper and then sent to the ‘PKU laboratory’ at
the Centre for Inherited Metabolic Diseases, the Karolinska
University Hospital in Stockholm where they are stored at
a temperature between +4 and +8°C, and kept available for
future purposes. The samples taken from the children with
ASD and their siblings were retrospectively identified
through their mothers’ referral numbers to the laboratory.
Each identified dried filter paper was then picked out from
its storage box and a 3.2 mm punch was sourced. All dried
blood samples were analysed at the Queensland Brain
Institute, University of Queensland, Brisbane, Australia
for 25(OH)D.Vitamin D analyses
25(OH)D can exist in two forms: 25-hydroxyvitamin D3
(25(OH)D3) and 25-hydroxyvitamin D2 (25(OH)D2); the
latter can only be obtained from dietary sources and
supplements. Both 25(OH)D3 and 25(OH)D2 were mea-
sured in the dried blood spots by using a highly sensitive
liquid chromatography-tandem mass spectroscopy assay
validated for dried blood spots [55]. This laboratory
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25(OH)D3 and 25(OH)D2 are highly protein-bound
steroids that are completely excluded from erythrocytes
[56]. Therefore, to make these results in whole blood
comparable with existing studies in sera, 25(OH)D3 and
25(OH)D2 concentrations were summed and reported as
adjusted serum 25(OH)D concentrations [55]. This re-
quired a correction based on a standard neonatal capillary
hematocrit of 0.61 [57]. In the present study 25(OH)D2
was present in only three of the 117 samples. Therefore all
data are reported as total 25(OH)D. The laboratory inves-
tigators were blind to diagnosis.Ethics
The study was approved at the Ethics Committees at the
University of Gothenburg and at Karolinska Institutet.Statistics
Since the data were non-normally distributed, several
methods were used to circumvent this. For the compari-
sons between cases and sibling controls we used paired t-
tests, confirming the results with the boot strap method.
We checked the results by means of the Wilcoxon paired
sample test and by square root transformation of 25(OH)
D values for use in t-tests, obtaining essentially similar
results (data not shown). Otherwise, basic statistics were
applied. Given our main hypothesis of lower vitamin D
status in ASD compared to controls, a case could be
made for one-tailed tests, however, our results are con-
servatively reported as two-tailed with probabilities
<0.05 accepted as significant. For the bootstrap method,
SPSS was used; all other calculations were performed
with Statistica 64, version 10, StatSoft Inc.Figure 2 Distribution of 25(OH)D levels in the total group of childrenSeason of birth (winter: December-February; spring:
March-May; summer: June-August and autumn: September-
November) was assigned for each individual. Because
analysis of pairs born during the same season resulted
in extremely small sample sizes, we used semesters of
birth instead (winter: October-March; summer: April-
September) in accordance with a previous Swedish
study [58].Results
25-hydroxyvitamin D related to cohort, ethnicity and
birth order in the total sample
Children to parents of non-Scandinavian ethnicities had
lower mean 25(OH)D levels than children to Swedish
parents. The lowest 25(OH)D levels were found in chil-
dren with African and Middle East origin. The mean 25
(OH)D level was 40.3 nM, SD = 24.9 in the children with
Swedish origin; 31.9 nM, SD = 24.9 in children with other
European (non-Scandinavian) origin; 25.6 nM, SD = 24.2
in children with East Asian origin; 22.4 nM, SD = 11.8 in
children with the South American origin; 11.5 nM,
SD = 7.1 in children with Middle East origin and lowest,
7.0 nM, SD = 5.0 in children with Somali origin. The
distribution of 25(OH)D levels among the Swedish,
Miscellaneous and African/Middle East origin children,
respectively, are shown in Figure 2.
Gender distribution and age relations between the sib-
ling pairs in the two cohorts are detailed in Table 1. Out
of the pairs, 23 were male-male, five were female-female,
29 were male-female, and one was female-male. Two of
the children with ASD were born by the same mother.
Age relations in sibling pairs are shown in Table 1. The
birth order between the child with ASD and his/her sib-
ling was unrelated to the 25(OH)D levels.(ASD and non-ASD) with different ethnic origin.
Table 1 Gender and median age difference between the ASD child and his/her sibling
Gothenburg catchment
area group (47 sibling pairs)
Stockholm Somali
group (11 sibling pairs)
Total (58 sibling pairs)
Gender in ASD group: M/F (% males) 42/5 (89%) 10/1 (91%) 52/6 (90%)
Gender in sibling group: M/F (% males) 18/28 (39%) 5/6 (45%) 23/34 (40%)
Age relation in sibling pairs: n; median difference, years (1st - 3rd quartiles)
ASD sibling older 14; 1.8 (1.2-2.1) 7; 3.5 (2.3-4.8) 21; 1.8 (1.5-2.8)
ASD sibling younger 32; 2.4 (1.8-4.2) 4; 2.5 (1.8-3.6) 36; 2.4 (1.8-4.1)
Twins (dizygotic) 1; 0.0 (0.0) - 1; 0.0 (0.0)
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ASD and sibling without ASD)
The mean 25(OH)D level was lower in children with
ASD (M = 24.0 nM, SD = 19.6, n = 58) than in their sib-
lings (M = 31.9 nM, SD = 27.7, n = 57). The difference in
mean 25(OH)D was significant according to a paired
samples t-test (t57 = 2.57, P = 0.013, d = 0.33). Since dif-
ference scores were highly skewed (skewness = 1.86),
SPSS bootstrap for paired samples test was performed
using 10,000 bootstrap samples. The bootstrap method
confirmed that the difference in mean 25(OH)D was sig-
nificant (P = 0.026, 95% confidence interval for the mean
difference: 2.24 - 14.21). Comparisons between the ASD
and non-ASD sibling in the three ethnic groups, Swed-
ish, Miscellaneous and African/Middle East, are shown
in Table 2. Significant differences were found between
the ASD and the non-ASD siblings in the Swedish and
Miscellaneous groups, but not in the African/Middle
East group.
25-hydroxyvitamin D in children with ASD related to IQ
There was no relation between IQ and vitamin D level,
that is, the group with intellectual disability did not dis-
play lower 25(OH)D levels compared to those without.
Season of birth
In the total sample, the difference in season of birth be-
tween children with ASD and their siblings was not sig-
nificant (χ2 = 5.5 DF = 3, P = 0.090, n = 115), although
34% of all children with ASD and only 19% of their sib-
lings were born in spring.
In a second analysis considering the different ethnic
groups, we joined the sibling pairs into only two groups,
due to the small sample sizes. In the Swedish +Miscel-
laneous group the season of birth of children with ASDTable 2 Mean 25(OH)D in the children with ASD compared to
Mothers’ ethnic origin ASD child Mean 25(OH)D, nM (SD)
Swedish, n = 28 34.5 (20.1)
Miscellaneous, n = 12 23.1 (16.5)
African/Middle East, n = 18 8.4 (5.6)
aDue to skewness, these results are calculated on square root transformed values.differed significantly from that of their non-ASD siblings
(χ2 = 8.9, DF = 3, P = 0.030, n = 80), as 38% versus 18%
were born in spring and 10% versus 35% in summer.
However, in the sibling pairs with African/Middle East ori-
gin no such season of birth difference emerged (χ2 = 1.5,
DF = 3, P = 0.69, n = 36).
To examine if the lower level of 25(OH)D in children
with ASD as compared to the level in their non-ASD
siblings correlated with season of birth, pairs for which
both siblings were born during the same six months
(Nov-Apr =Winter, n = 13 and May-Oct = Summer, n = 14)
were selected. Both for siblings born during the winter
months and for siblings born during the summer months,
the mean 25(OH)D level was lower for children with ASD
than for their non-ASD siblings, with similar effect size.
For pairs of children born during the winter months, the
mean 25(OH)D level for children with ASD was M = 23.7
nM (SD = 10.7, n = 13) and for their non-ASD siblings the
mean 25(OH)D level was M = 26.7 nM (SD = 17.4, n = 13):
t12 = 0.59, P = 0.563, d = 0.21). For pairs of children born
during the summer months, the mean 25(OH)D level for
children with ASD was M = 32.4 nM (SD = 21.3, n = 14)
and for their non-ASD siblings the mean 25(OH)D level
was M = 39.4 nM (SD = 24.4, n = 14): t13 = 1.36, P = 0.196,
d = 0.31).
Discussion
Children with ASD had had lower 25(OH)D levels at
birth compared to their non-ASD siblings which most
likely was not accounted for by season of birth effects.
The findings were seemingly consistent regardless of
ethnicity, IQ level and birth order. The study - to our
knowledge - is the first in which vitamin D levels in
dried blood spots, from the newborn period, have been
analysed in samples of children with ASD and in theirhis/her sibling, separated by ethnic origin
Non-ASD sibling Mean 25(OH)D, nM (SD) t (df)a Pa
46.8 (27.8) -2.14 (27) 0.042
31.2 (24.0) -1.55 (11) 0.015
9.2 (6.9) -.42 (17) 0.68
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onmental and genetic causes for ASD. The participants
were recruited from two distinct cohorts of Swedish
born children with ASD; one drawn from a representa-
tive group of children with ASD, living in Gothenburg,
the other consisting of children with ASD and with Somali
background, living in Stockholm and representing high
risk for vitamin D deficiency.
Ethnicity
Children with ASD in the collapsed sample and in the
Swedish and Miscellaneous groups had significantly lower
25(OH)D levels at birth compared to their non-ASD sib-
lings. However in the African/Middle East group a startling
floor effect prevented any meaningful comparison in 25
(OH)D levels between cases and controls. All these sib-
lings had levels corresponding to 20% of the children of
Swedish origin. This is in line with other Scandinavian re-
search, showing that Somali born women have the lowest
vitamin D levels of all ethnic groups reported in Sweden
[37], even lower than in Turkish and Pakistani mothers
living in Norway [59]. In a separate study looking at preg-
nant Somali-born women in Sweden, 25(OH)D levels
were below the detection level of that laboratory (10 nM)
in one-third of the cases and below 25 nM in 90% of the
cases [60]. Accordingly, the Swedish Somali women and
women from the Middle East seem particularly vulnerable
to low vitamin D levels, affecting the vitamin D status of
the offspring, presumably due to both dark skin [32] and
covered clothing.
Seasonal effects
Our finding that more children with ASD of Swedish or
other non-African/non-Middle East background were born
in the spring than during other seasons - could possibly
implicate other aetiological factors than vitamin D levels,
such as, for instance, infections. However, the lack of ef-
fect of season of sampling (= season of birth in our study)
on 25(OH)D levels in our African/Middle East group, all
having low vitamin D status throughout the year, has also
been reported in women with African/Middle East origin
living in Norway [59]. In conjunction with the elevated in-
cidence of ASD in these populations, this may support a
role of vitamin D deficiency - rather than other seasonal
factors - in the development of autism. Moreover, even in
sibling pairs born within the same 6-month period (result-
ing in very small numbers for comparison), the ASD sib-
ling had consistently lower levels than the control sibling
and with similar effect size as in the total group.
25(OH)D levels in other studies on ASD participants
Several studies report lower 25(OH)D levels in individuals
with ASD compared to controls [49-53]. Our findings of
lower vitamin D levels in children with ASD, comparedto their siblings, also accord with results from a population-
based study from the Faroe Islands, in the North Atlantic
Ocean, of vitamin D levels in adolescents and young
adults with ASD. Significantly lower 25(OH)D levels were
found in the group with ASD, compared to both their sib-
lings without ASD, their parents and also in comparison
to a healthy age and gender matched group [46]. Previous
findings of low levels of vitamin D could reflect the conse-
quences of ASD per se, that is, the impact of a person’s in-
door lifestyle and circumscribed diet. Since we studied
newborn children before diagnosis, our results are def-
initely unrelated to lifestyle and diet of the individual,
although the mother’s lifestyle and other environmental
factors cannot be ruled out.
Genetics and 25(OH)D levels
Genetic causes for low 25(OH)D levels have been sug-
gested, related to, for example, synthesising enzymes and
transport proteins [61,62]. The consistently low levels of
25(OH)D found in individuals with ASD, from the neo-
natal period up to adulthood, thus may be related, not
only to environmental factors (UV exposure and diet),
but possibly also to genetic predispositions. However, to
our knowledge, no 25(OH)D-related gene has been im-
plicated in genomic studies of ASD. On the other hand,
a link between genomic actions of vitamin D and seroto-
nergic deviations in ASD has been proposed by Patrick
and Ames [63]. According to these authors, low levels of
vitamin D may simultaneously cause hypo-activity of the
central serotonergic system and hyperactivity of the per-
ipheral, causing hyperserotoninemia, one of the most
replicated biomarkers in ASD research [64].
Strengths and limitations
The participants of this study represent different ethnic
backgrounds, IQ levels ranging from intellectual disability
to normal intelligence, and highly variable newborn vita-
min D levels. This, along with the study design, allowing
comparison between siblings, and the thorough assess-
ment of the children with ASD, all constitute strengths of
this study. While the children with ASD were investigated
for intelligence level and co-morbidity, the sibling controls
were not assessed in person, which is a limitation. How-
ever, all children with ASD belonging to the catchment
area are registered in the patient registry at the Child
Neuropsychiatry Clinic in Gothenburg. If a sibling was
diagnosed with ASD we would be informed and some
siblings were indeed excluded due to ASD after the
study was initiated. Nevertheless, we cannot rule out
that additional siblings will be diagnosed with ASD at a
later stage, as some children with ASD and normal IQ
are not identified until adolescence or later. On the other
hand, if a child is diagnosed with ASD after the age of
4 years (which was the youngest age of the sibling controls
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than the index child.
The total sample size was small and not representative
with regard to sex ratio in the ASD group, since there
were only six girls in the total group of 58 children.
Concerning this atypical gender ratio, we cannot explain
the high male preponderance in our sample, which may
constitute a chance finding. Among the healthy siblings
the majority were girls. However, no difference in vita-
min D levels related to gender has been found in neo-
nates [65]. More children with ASD were younger than
their non-ASD sibling, which could be taken to suggest
older parents at birth of the child with ASD (a known
risk factor for ASD). However, the age difference within
the sibling pairs is more likely a consequence of our
sample selection principle: we included children with an
ASD diagnosis of age 4 years or older and their siblings
also at an age of 4 years or older (so as to minimise the
risk that the sibling might have a diagnosis of ASD),
meaning that really young siblings could not be included
in the study.
The high prevalence of migrant mothers in a Swedish
born group of children with ASD, could be viewed as a
limitation. In the Gothenburg catchment area group,
41% had foreign ethnicity, reflecting the high frequency
of ASD among second-generation immigrants of non-
Scandinavian origin reported also in previous studies
[54,66]. Similarly, increased rates of ASD were reported
from Finland in offspring to migrant mothers [67]. The
Finnish study was based on very large numbers drawn
from the Finnish Central Population Register suggesting
that our limited sample may nevertheless be representa-
tive. Also, in a recent study including 7,540 children with
autism drawn from a cohort of more than 1.5 million
births, non-white American mothers had increased risk
for having a child with ASD compared to white American
mothers [68]. Foreign-born black mothers were at highest
risk of having a child with both severe emotional out-
bursts and impaired expressive language. This clinical
description is remarkably consistent with the clinical
picture of the Swedish Somali children with ASD in-
cluded in our study [28,29].
In this study we did not examine other possible causes
for ASD, such as for instance infections during pregnancy.
Infections are more prevalent during late winter months
and thus could explain the increased risk for ASD in chil-
dren born in early spring which coincide with low 25(OH)
D levels. However, CMV-infections were examined from
the dried blood spots, and no child with ASD in our study
group was found to be affected (yet unpublished data).
Autoimmunity is another possible cause for ASD, which
was not investigated. However, as low vitamin D is sug-
gested to contribute to the pathogenesis of autoimmunity
[69], our findings could be relevant in this context as well.Conclusion
Our findings of a low vitamin D level in a group of new-
born children, who later developed ASD, provide support
for the hypothesis that developmental vitamin D defi-
ciency during late pregnancy may carry an increased risk
of ASD in the child, along with several other risk factors.
Three different independent findings point towards a role
for vitamin D in the development of ASD: (1) Increased
risk for ASD in offspring of migrants, especially from
countries with a dark-skinned population and from cul-
tures where women use covered clothing; (2) low 25(OH)
D levels in groups of newborn children, who later have de-
veloped ASD, and in groups of children and adults with
ASD; and (3) an association between season of birth and
ASD, in our study not extending to the high-risk groups
of migrants, suggesting that these groups are exposed to
suboptimal vitamin D levels the whole year. Although
low levels of vitamin D could have a genetic origin and
as such be associated with ASD, our study is the first to
rule out ASD-related lifestyle mechanisms as explan-
ation for low 25(OH)D levels, since the samples were
taken in the newborn period. Future research should in-
clude a larger cohort followed prospectively and also
study whether or not adequate supplementation of vita-
min D to pregnant women might lower the risk for ASD
in the offspring.
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